Genetic testing for chemotherapy in non-small cell lung cancer

Schiller, 2002, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, New Engl. J. Med., 346, 92, 10.1056/NEJMoa011954 Rosell, 2002, Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial, Ann. Oncol., 13, 1539, 10.1093/annonc/mdf332 Phillips, 2002, The formation of DNA adducts, 293 Siddik, 2002, Mechanisms of action of cancer chemotherapeutic agents: DNA-interactive alkylating agents and antitumour platinum-based drugs, 1295 Hanawalt, 2001, Controlling the efficiency of excision repair, Mut. Res., 485, 3, 10.1016/S0921-8777(00)00071-9 May, 1993, Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin, J. Biol. Chem., 268, 1650, 10.1016/S0021-9258(18)53902-8 McKay, 1998, Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis, Oncogene, 17, 545, 10.1038/sj.onc.1201963 Cullinane, 1999, Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage, Biochemistry, 38, 6204, 10.1021/bi982685+ Conforti, 2000, Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation, Oncogene, 19, 2714, 10.1038/sj.onc.1203583 Takebayashi, 2001, Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors, Cancer Lett., 174, 115, 10.1016/S0304-3835(01)00690-5 McKay, 2001, p53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts, Oncogene, 20, 6805, 10.1038/sj.onc.1204901 Furuta, 2002, Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells, Cancer Res., 62, 4899 Takebayashi, 2001, Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair, Nat. Med., 7, 961, 10.1038/91008 Damia, 2001, Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways, Int. J. Cancer, 92, 583, 10.1002/ijc.1221 Metzger, 1998, ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy, J. Clin. Oncol., 16, 309, 10.1200/JCO.1998.16.1.309 Shirota, 2001, ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy, J. Clin. Oncol., 119, 4298, 10.1200/JCO.2001.19.23.4298 Lord, 2002, Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small-cell lung cancer, Clin. Cancer Res., 8, 2286 Spitz, 2001, Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients, Cancer Res., 61, 1354 Bosken, 2002, An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer, J. Natl. Cancer Inst., 94, 1091, 10.1093/jnci/94.14.1091 Poirier, 1992, Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients, Cancer Res., 52, 149 Schaake-Koning, 1992, Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer, New Engl. J. Med., 326, 524, 10.1056/NEJM199202203260805 Van de Vaart, 2000, DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy, Int. J. Cancer (Pred. Oncol.), 89, 160, 10.1002/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J Rajewsky, 2002, DNA repair and the cell cycle as targets in cancer therapy, 1507